V Convención de la Profesión Médica

V Convención de la Profesión Médica • ´t Hoen E. Indian hepatitis C drug patent decision shakes public health community. 2016 june 4;387:2272-3. www.thelancet.com. • Vallas S, Kleinman D, Biscotti D. Political structures and the making of U.S. biotechnology. In: Block F and Keller M, eds. State of Innovation: the US government’s role in technology development. Boulder: Paradigm; 2011;57-76. • WHO. The World Medicines Situation. World Health Organization, 2004. • WHO. Public health, innovation and intellectual property rights: report of the Commission on Intellectual Property Rights, Innovation and Public Health. 2006. • WHO. Research and Development to Meet Health Needs in Developing Countries: Strengthening Global Financing and Coordination. Report of the Consultative Expert Working Group on Research and Development: Financing and Coordination. Geneva. World Health Organization, 2012. • WHO. Sixty-Fifth World Assembly, Geneva 21-26 May 2012. Resolutions and Decisions. WHA 65 22 Resolution: Follow-up of the report of the Consultative Expert Working Group on Research and Development: financing and coordination. 2012;37- 8. • WHO. Global Action Plan on antimicrobial resistance. 2015. http://www.who.int/drugresistance/global_action_plan/en/. WIPO (2004). Handbook on intellectual property. World Intellectual Property Organization. 2004. Reprinted 2008. • WTO. Agreement on Trade-Related Aspects of Intellectual Property Rights, 15 April 1994. • WTO. Declaration on the TRIPS agreement and Public Health, Doha 14 Nov 2001. • Wyden-Grassley Report. The price of Sovaldi and its impact on the U.S. Health Care System. Senate Finance Committee, United States Senate. December 2015. http://www.finance.senate.gov/newsroom/ ranking/release/?id=3f693c73-0fc2- 4a4c-ba92-562723ba5255.